124 research outputs found

    The Spitzer c2d Survey of Nearby Dense Cores. V. Discovery of a VeLLO in the "Starless" Dense Core L328

    Get PDF
    This paper reports the discovery of a Very Low Luminosity Object (VeLLO) in the "starless" dense core L328, using the Spitzer Space Telescope and ground based observations from near-infrared to millimeter wavelengths. The Spitzer 8 micron image indicates that L328 consists of three subcores of which the smallest one may harbor a source, L328-IRS while two other subcores remain starless. L328-IRS is a Class 0 protostar according to its bolometric temperature (44 K) and the high fraction ~72 % of its luminosity emitted at sub-millimeter wavelengths. Its inferred "internal luminosity" (0.04 - 0.06 Lsun) using a radiative transfer model under the most plausible assumption of its distance as 200 pc is much fainter than for a typical protostar, and even fainter than other VeLLOs studied previously. Note, however, that its inferred luminosity may be uncertain by a factor of 2-3 if we consider two extreme values of the distance of L328-IRS (125 or 310 pc). Low angular resolution observations of CO do not show any clear evidence of a molecular outflow activity. But broad line widths toward L328, and Spitzer and near-infrared images showing nebulosity possibly tracing an outflow cavity, strongly suggest the existence of outflow activity. Provided that an envelope of at most ~0.1 Msunis the only mass accretion reservoir for L328-IRS, and the star formation efficiency is close to the canonical value ~30%, L328-IRS has not yet accreted more than 0.05 Msun. At the assumed distance of 200 pc, L328-IRS is destined to be a brown dwarf.Comment: 29 pages, 8 figures, 1 table, to be published in Astrophysical Journa

    Mid-JJ CO Line Observations of Protostellar Outflows in the Orion Molecular Clouds

    Full text link
    Ten protostellar outflows in the Orion molecular clouds were mapped in the 12^{12}CO/13^{13}CO J=65{J=6\rightarrow5} and 12^{12}CO J=76{J=7\rightarrow6} lines. The maps of these mid-JJ CO lines have an angular resolution of about 10'' and a typical field size of about 100''. Physical parameters of the molecular outflows were derived, including mass transfer rates, kinetic luminosities, and outflow forces. The outflow sample was expanded by re-analyzing archival data of nearby low-luminosity protostars, to cover a wide range of bolometric luminosities. Outflow parameters derived from other transitions of CO were compared. The mid-JJ (Jup6J_{\rm up} \approx 6) and low-JJ (Jup3J_{\rm up} \leq 3) CO line wings trace essentially the same outflow component. By contrast, the high-JJ (up to Jup50J_{\rm up} \approx 50) line-emission luminosity of CO shows little correlation with the kinetic luminosity from the J=65{J=6\rightarrow5} line, which suggests that they trace distinct components. The low/mid-JJ CO line wings trace long-term outflow behaviors while the high-JJ CO lines are sensitive to short-term activities. The correlations between the outflow parameters and protostellar properties are presented, which shows that the strengths of molecular outflows increase with bolometric luminosity and envelope mass.Comment: 31 pages, 16 figures, Accepted for publication in ApJ

    Zanthoxylum ailanthoides

    Get PDF
    Zanthoxylum ailanthoides (ZA) has been used as folk medicines in East Asian and recently reported to have several bioactivity; however, the studies of ZA on the regulation of triacylglycerol (TG) biosynthesis have not been elucidated yet. In this study, we examined whether the methanol extract of ZA (ZA-M) could reduce oleic acid- (OA-) induced intracellular lipid accumulation and confirmed its mode of action in HepG2 cells. ZA-M was shown to promote the phosphorylation of AMPK and its upstream LKB1, followed by reduction of lipogenic gene expressions. As a result, treatment of ZA-M blocked de novo TG biosynthesis and subsequently mitigated intracellular neutral lipid accumulation in HepG2 cells. ZA-M also inhibited OA-induced production of reactive oxygen species (ROS) and TNF-α, suggesting that ZA-M possess the anti-inflammatory feature in fatty acid over accumulated condition. Taken together, these results suggest that ZA-M attenuates OA-induced lipid accumulation and inflammation through the activation of LKB1/AMPK signaling pathway in HepG2 cells

    Efficient Cultivation Conditions for Human Limbal Epithelial Cells

    Get PDF
    To compare the stem niche in different culture conditions of limbal epithelial cells, the suspended human limbal epithelial cells (HLECs) were seeded on the 3T3-pretreated plates and the other suspended cells were plated on amniotic membranes (AMs) which were either cryo-preserved or freeze-dried. All were cultured for 10 to 12 days. Reverse transcription-polymerase chain reaction (RT-PCR) for ATP-binding casette, subfamily G, member 2 (ABCG2), p63, cytokeratin 12, and connexin 43 were performed in cultivated HLECs and their expression levels were compared. The mRNA expression of all markers examined showed no statistically significant differences between the cells on cryo-preserved and on freeze-dried AM. The expression of p63 and cytokeratin 12 in cultivated cells on AMs were significantly lower than those in 3T3-cocultured cells on RT-PCR and immunofluorescent staining. Cultivated HLECs on AMs showed reduced proliferation and differentiation while maintaining stem-property regardless of the preservative method of AM

    Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features

    Get PDF
    Background. Candida haemulonii, a yeast species that often exhibits antifungal resistance, rarely causes human infection. During 2004-2006, unusual yeast isolates with phenotypic similarity to C. haemulonii were recovered from 23 patients (8 patients with fungemia and 15 patients with chronic otitis media) in 5 hospitals in Korea. Methods. Isolates were characterized using D1/D2 domain and ITS gene sequencing, and the susceptibility of the isolates to 6 antifungal agents was tested in vitro. Results. Gene sequencing of the blood isolates confirmed C. haemulonii group I (in 1 patient) and Candida pseudohaemulonii (in 7 patients), whereas all isolates recovered from the ear were a novel species of which C. haemulonii is its closest relative. The minimum inhibitory concentration (MIC) ranges of amphotericin B, fluconazole, itraconazole, and voriconazole for all isolates were 0.5-32 mu g/mL (MIC(50), 1 mu g/mL), 2-128 mu g/mL (MIC(50), 4 mu g/mL), 0.125-4 mu g/mL (MIC(50), 0.25 mu g/mL), and 0.03-2 mu g/mL (MIC(50), 0.06 mu g/mL), respectively. All isolates were susceptible to caspofungin (MIC, 0.125-0.25 mu g/mL) and micafungin (MIC, 0.03-0.06 mu g/mL). All cases of fungemia occurred in patients with severe underlying diseases who had central venous catheters. Three patients developed breakthrough fungemia while receiving antifungal therapy, and amphotericin B therapeutic failure, which was associated with a high MIC of amphotericin B (32 mu g/mL), was observed in 2 patients. Conclusions. Candida species that are closely related to C. haemulonii are emerging sources of infection in Korea. These species show variable patterns of susceptibility to amphotericin B and azole antifungal agents.Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07Khan ZU, 2007, J CLIN MICROBIOL, V45, P2025, DOI 10.1128/JCM.00222-07Lee JS, 2007, J CLIN MICROBIOL, V45, P1005, DOI 10.1128/JCM.02264-06Pfaller MA, 2006, J CLIN MICROBIOL, V44, P819, DOI 10.1128/JCM.44.3.819-826.2006Sugita T, 2006, MICROBIOL IMMUNOL, V50, P469Clancy CJ, 2005, ANTIMICROB AGENTS CH, V49, P3171, DOI 10.1128/AAC.49.8.3171-3177.2005Odds FC, 2004, J CLIN MICROBIOL, V42, P3475, DOI 10.1128/JCM.42.8.3475-3482.2004Rodero L, 2002, J CLIN MICROBIOL, V40, P2266, DOI 10.1128/JCM.40.6.2266-2269.2002*CLSI, 2002, M27A2 CLSISugita T, 1999, J CLIN MICROBIOL, V37, P1985Pfaller MA, 1998, DIAGN MICR INFEC DIS, V32, P223Nguyen MH, 1998, J INFECT DIS, V177, P425Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216LEHMANN PF, 1993, J CLIN MICROBIOL, V31, P1683GARGEYA IB, 1991, J MED VET MYCOL, V29, P335
    corecore